Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Amiodarone | The serum concentration of Cymarin can be increased when it is combined with Amiodarone. |
| Amphotericin B | The risk or severity of adverse effects can be increased when Amphotericin B is combined with Cymarin. |
| Clonidine | Clonidine may increase the atrioventricular blocking (AV block) activities of Cymarin. |
| Edrophonium | Edrophonium may increase the atrioventricular blocking (AV block) and arrhythmogenic activities of Cymarin. |
| Itraconazole | The serum concentration of Cymarin can be increased when it is combined with Itraconazole. |
| Kaolin | The serum concentration of Cymarin can be decreased when it is combined with Kaolin. |
| Midodrine | Cymarin may increase the bradycardic, atrioventricular blocking (AV block), and arrhythmogenic activities of Midodrine. |
| Propafenone | The serum concentration of Cymarin can be increased when it is combined with Propafenone. |
| Quinine | The serum concentration of Cymarin can be increased when it is combined with Quinine. |
| Quinidine | The serum concentration of Cymarin can be increased when it is combined with Quinidine. |
| Reserpine | The risk or severity of adverse effects can be increased when Reserpine is combined with Cymarin. |
| Telmisartan | The serum concentration of Cymarin can be increased when it is combined with Telmisartan. |
| Tolevamer | The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Cymarin. |
| Sulpiride | The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Cymarin. |
| Parathyroid hormone | The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Cymarin. |
| Calcitriol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcitriol is combined with Cymarin. |
| Calcifediol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcifediol is combined with Cymarin. |
| Ergocalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Ergocalciferol is combined with Cymarin. |
| Cholecalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Cholecalciferol is combined with Cymarin. |
| Paricalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Cymarin. |
| Dihydrotachysterol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Dihydrotachysterol is combined with Cymarin. |
| Alfacalcidol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Alfacalcidol is combined with Cymarin. |
| Seocalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Seocalcitol is combined with Cymarin. |
| Inecalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Inecalcitol is combined with Cymarin. |
| Becocalcidiol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Becocalcidiol is combined with Cymarin. |
| Eldecalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Eldecalcitol is combined with Cymarin. |
| 1alpha,24S-Dihydroxyvitamin D2 | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Cymarin. |
| Elocalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Elocalcitol is combined with Cymarin. |
| Maxacalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Maxacalcitol is combined with Cymarin. |
| Doxercalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Doxercalciferol is combined with Cymarin. |
| Vitamin D | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Vitamin D is combined with Cymarin. |
| 1alpha-Hydroxyvitamin D5 | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when 1alpha-Hydroxyvitamin D5 is combined with Cymarin. |
| Previtamin D(3) | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Previtamin D(3) is combined with Cymarin. |
| Labetalol | Labetalol may increase the bradycardic activities of Cymarin. |
| Pindolol | Pindolol may increase the bradycardic activities of Cymarin. |
| Bevantolol | Bevantolol may increase the bradycardic activities of Cymarin. |
| Penbutolol | Penbutolol may increase the bradycardic activities of Cymarin. |
| Bufuralol | Bufuralol may increase the bradycardic activities of Cymarin. |
| Bopindolol | Bopindolol may increase the bradycardic activities of Cymarin. |
| Arotinolol | Arotinolol may increase the bradycardic activities of Cymarin. |
| Levobetaxolol | Levobetaxolol may increase the bradycardic activities of Cymarin. |
| Bucindolol | Bucindolol may increase the bradycardic activities of Cymarin. |
| Esatenolol | Esatenolol may increase the bradycardic activities of Cymarin. |
| Cloranolol | Cloranolol may increase the bradycardic activities of Cymarin. |
| Mepindolol | Mepindolol may increase the bradycardic activities of Cymarin. |
| Epanolol | Epanolol may increase the bradycardic activities of Cymarin. |
| Erythromycin | The serum concentration of Cymarin can be increased when it is combined with Erythromycin. |
| Azithromycin | The serum concentration of Cymarin can be increased when it is combined with Azithromycin. |
| Sirolimus | The serum concentration of Cymarin can be increased when it is combined with Sirolimus. |
| Dirithromycin | The serum concentration of Cymarin can be increased when it is combined with Dirithromycin. |
| Telithromycin | The serum concentration of Cymarin can be increased when it is combined with Telithromycin. |
| Candicidin | The serum concentration of Cymarin can be increased when it is combined with Candicidin. |
| Clarithromycin | The serum concentration of Cymarin can be increased when it is combined with Clarithromycin. |
| Josamycin | The serum concentration of Cymarin can be increased when it is combined with Josamycin. |
| Everolimus | The serum concentration of Cymarin can be increased when it is combined with Everolimus. |
| Epothilone D | The serum concentration of Cymarin can be increased when it is combined with Epothilone D. |
| Patupilone | The serum concentration of Cymarin can be increased when it is combined with Patupilone. |
| 6-Deoxyerythronolide B | The serum concentration of Cymarin can be increased when it is combined with 6-Deoxyerythronolide B. |
| Ixabepilone | The serum concentration of Cymarin can be increased when it is combined with Ixabepilone. |
| KOS-1584 | The serum concentration of Cymarin can be increased when it is combined with KOS-1584. |
| Ridaforolimus | The serum concentration of Cymarin can be increased when it is combined with Ridaforolimus. |
| Temsirolimus | The serum concentration of Cymarin can be increased when it is combined with Temsirolimus. |
| AVE9633 | The serum concentration of Cymarin can be increased when it is combined with AVE9633. |
| Coltuximab ravtansine | The serum concentration of Cymarin can be increased when it is combined with Coltuximab ravtansine. |
| Cethromycin | The serum concentration of Cymarin can be increased when it is combined with Cethromycin. |
| Mitemcinal | The serum concentration of Cymarin can be increased when it is combined with Mitemcinal. |
| Brefeldin A | The serum concentration of Cymarin can be increased when it is combined with Brefeldin A. |
| Solithromycin | The serum concentration of Cymarin can be increased when it is combined with Solithromycin. |
| Kitasamycin | The serum concentration of Cymarin can be increased when it is combined with Kitasamycin. |
| Carbomycin | The serum concentration of Cymarin can be increased when it is combined with Carbomycin. |
| Doramectin | The serum concentration of Cymarin can be increased when it is combined with Doramectin. |
| Eprinomectin | The serum concentration of Cymarin can be increased when it is combined with Eprinomectin. |
| Oleandomycin | The serum concentration of Cymarin can be increased when it is combined with Oleandomycin. |
| Selamectin | The serum concentration of Cymarin can be increased when it is combined with Selamectin. |
| Tildipirosin | The serum concentration of Cymarin can be increased when it is combined with Tildipirosin. |
| Tilmicosin | The serum concentration of Cymarin can be increased when it is combined with Tilmicosin. |
| Tylosin | The serum concentration of Cymarin can be increased when it is combined with Tylosin. |
| Tylvalosin | The serum concentration of Cymarin can be increased when it is combined with Tylvalosin. |
| Bryostatin 1 | The serum concentration of Cymarin can be increased when it is combined with Bryostatin 1. |
| Lorvotuzumab mertansine | The serum concentration of Cymarin can be increased when it is combined with Lorvotuzumab mertansine. |
| Epofolate | The serum concentration of Cymarin can be increased when it is combined with Epofolate. |
| Sagopilone | The serum concentration of Cymarin can be increased when it is combined with Sagopilone. |
| Troleandomycin | The serum concentration of Cymarin can be increased when it is combined with Troleandomycin. |
| Miocamycin | The serum concentration of Cymarin can be increased when it is combined with Miocamycin. |
| Flurithromycin | The serum concentration of Cymarin can be increased when it is combined with Flurithromycin. |
| Rokitamycin | The serum concentration of Cymarin can be increased when it is combined with Rokitamycin. |
| Midecamycin | The serum concentration of Cymarin can be increased when it is combined with Midecamycin. |
| Clindamycin | The serum concentration of Cymarin can be increased when it is combined with Clindamycin. |
| Mepartricin | The serum concentration of Cymarin can be increased when it is combined with Mepartricin. |
| Succinylcholine | The risk or severity of Cardiac Arrhythmia can be increased when Succinylcholine is combined with Cymarin. |
| Metocurine iodide | The risk or severity of Cardiac Arrhythmia can be increased when Metocurine iodide is combined with Cymarin. |
| Gallamine triethiodide | The risk or severity of Cardiac Arrhythmia can be increased when Gallamine triethiodide is combined with Cymarin. |
| Cisatracurium | The risk or severity of Cardiac Arrhythmia can be increased when Cisatracurium is combined with Cymarin. |
| Rocuronium | The risk or severity of Cardiac Arrhythmia can be increased when Rocuronium is combined with Cymarin. |
| Atracurium besylate | The risk or severity of Cardiac Arrhythmia can be increased when Atracurium besylate is combined with Cymarin. |
| Doxacurium | The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Cymarin. |
| Tubocurarine | The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Cymarin. |
| Mivacurium | The risk or severity of Cardiac Arrhythmia can be increased when Mivacurium is combined with Cymarin. |
| Decamethonium | The risk or severity of Cardiac Arrhythmia can be increased when Decamethonium is combined with Cymarin. |
| Metocurine | The risk or severity of Cardiac Arrhythmia can be increased when Metocurine is combined with Cymarin. |